GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 29574006
Publication Date: 2018/03/21

A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).


Loss-of-function mutations in cytochrome P450 family 24 subfamily A member 1 (CYP24A1) gene are associated with Idiopathic Infantile Hypercalcemia (IIH) and adult kidney stone disease. The enzyme deficiency leads to an impaired vitamin D catabolism pathway, resulting in a syndrome characterized by recurrent hypercalcemia, hypercalciuria and suppressed parathyroid hormone (PTH) levels. In these patients, the genetic evaluation of CYP24A1 is an important diagnostic tool, allowing the definitive diagnosis of IIH.

A rapid CYP24A1 gene testing based on High Resolution Melting Analysis (HRMA) was designed in order to detect the CYP24A1 c.428_430delAAG (p.Glu143del), a recurrent IIH-associated variant.

HRMA method was able to identify c.428_430delAAG genotypes evaluating melting curve shape and melting temperature (T). Heterozygous samples exhibited a typical melting profile while homozygous samples showed a specific T shift.

We provide evidence about application of HRMA in unambiguous genotyping of the CYP24A1 c.428_430delAAG variant, making this method useful in clinical molecular diagnostics. This approach opens the way to a helpful molecular analysis of CYP24A1 gene in IIH diagnosis, to an improved pharmacological treatment strategy and to a reduced risk of recurrent stones and worsening nephrocalcinosis.
Authors: De Paolis Elisa , Minucci Angelo , De Bonis Maria , Scaglione Giovanni Luca , Gervasoni Jacopo , Primiano Aniello , Ferraro Pietro Manuel , Cappellani Daniele , Marcocci Claudio , Gambaro Giovanni , Capoluongo Ettore ,

Reference:

  1. ncbi.nlm.nih.gov. [Last access 2018/03/21].

Related products :

Catalog number Product name Quantity
CLN9 CLN6 Gene ceroid-lipofuscinosis, neuronal 6, late infantile, variant
CSB-EL005568DO Dog ceroid-lipofuscinosis, neuronal 6, late infantile, variant (CLN6) ELISA kit, Species Dog, Sample Type serum, plasma 96T
B741 Staphylococcus Agar No.110 w_Azide USE : For selective isolation and testing of pathogenic Staphylococci. 5x500gm
B741 Staphylococcus Agar No.110 w_Azide USE For selective isolation and testing of pathogenic Staphylococci. Qty per Litre of Medium: 149,6
CSB-EL005568HU Human ceroid-lipofuscinosis, neuronal 6, late infantile, variant (CLN6) ELISA kit, Species Human, Sample Type serum, plasma 96T